Literature DB >> 26032504

Ablation of Dicer leads to widespread perturbation of signaling pathways.

Nandini A Sahasrabuddhe1, Tai-Chung Huang2, Praveen Kumar3, Yi Yang2, Bidyut Ghosh4, Steven D Leach5, Raghothama Chaerkady6, Akhilesh Pandey7.   

Abstract

Dicer is an essential ribonuclease involved in the biogenesis of miRNAs. Previous studies have reported downregulation of Dicer in multiple cancers including hepatocellular carcinoma. To identify signaling pathways that are altered upon Dicer depletion, we carried out quantitative phosphotyrosine profiling of liver tissue from Dicer knockout mice. We employed antibody-based enrichment of phosphotyrosine containing peptides coupled with SILAC spike-in approach for quantitation. High resolution mass spectrometry-based analysis identified 349 phosphotyrosine peptides corresponding to 306 unique phosphosites of which 75 were hyperphosphorylated and 78 were hypophosphorylated. Several receptor tyrosine kinases including MET, PDGF receptor alpha, Insulin-like growth factor 1 and Insulin receptor as well as non-receptor tyrosine kinases such as Src family kinases were found to be hyperphosphorylated upon depletion of Dicer. In addition, signaling molecules such as IRS-2 and STAT3 were hyperphosphorylated. Activation of these signaling pathways has been implicated previously in various types of cancers. Interestingly, we observed hypophosphorylation of molecules including focal adhesion kinase and paxillin. Our study profiles the perturbed signaling pathways in response to dysregulated miRNAs resulting from depletion of Dicer. Our findings warrant further studies to investigate oncogenic effects of downregulation of Dicer in cancers.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dicer; Pathways; Phosphotyrosine; Receptor tyrosine kinase; SILAC

Mesh:

Substances:

Year:  2015        PMID: 26032504      PMCID: PMC4696065          DOI: 10.1016/j.bbrc.2015.05.077

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  Regulation of lipid metabolism by Dicer revealed through SILAC mice.

Authors:  Tai-Chung Huang; Nandini A Sahasrabuddhe; Min-Sik Kim; Derese Getnet; Yi Yang; Jonathan M Peterson; Bidyut Ghosh; Raghothama Chaerkady; Steven D Leach; Luigi Marchionni; G William Wong; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2012-02-28       Impact factor: 4.466

2.  Systematic discovery of in vivo phosphorylation networks.

Authors:  Rune Linding; Lars Juhl Jensen; Gerard J Ostheimer; Marcel A T M van Vugt; Claus Jørgensen; Ioana M Miron; Francesca Diella; Karen Colwill; Lorne Taylor; Kelly Elder; Pavel Metalnikov; Vivian Nguyen; Adrian Pasculescu; Jing Jin; Jin Gyoon Park; Leona D Samson; James R Woodgett; Robert B Russell; Peer Bork; Michael B Yaffe; Tony Pawson
Journal:  Cell       Date:  2007-06-14       Impact factor: 41.582

3.  Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

Authors:  Yoko Karube; Hisaaki Tanaka; Hirotaka Osada; Shuta Tomida; Yoshio Tatematsu; Kiyoshi Yanagisawa; Yasushi Yatabe; Junichi Takamizawa; Shinichiro Miyoshi; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Sci       Date:  2005-02       Impact factor: 6.716

4.  Functional importance of Dicer protein in the adaptive cellular response to hypoxia.

Authors:  J J David Ho; Julie L Metcalf; Matthew S Yan; Paul J Turgeon; Jenny Jing Wang; Maria Chalsev; Tania N Petruzziello-Pellegrini; Albert K Y Tsui; Jeff Z He; Helena Dhamko; H S Jeffrey Man; G Brett Robb; Bin T Teh; Michael Ohh; Philip A Marsden
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

5.  Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors.

Authors:  A Pandey; A V Podtelejnikov; B Blagoev; X R Bustelo; M Mann; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Down-regulation of Dicer in hepatocellular carcinoma.

Authors:  Jin-Feng Wu; Wei Shen; Nian-Zhou Liu; Gui-Li Zeng; Mei Yang; Guo-Qing Zuo; Xiu-Ni Gan; Hong Ren; Kai-Fu Tang
Journal:  Med Oncol       Date:  2010-04-20       Impact factor: 3.064

Review 7.  Targeting the HGF/c-MET pathway in hepatocellular carcinoma.

Authors:  Lipika Goyal; Mandar D Muzumdar; Andrew X Zhu
Journal:  Clin Cancer Res       Date:  2013-02-06       Impact factor: 12.531

8.  Dicer, Drosha, and outcomes in patients with ovarian cancer.

Authors:  William M Merritt; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Whitney A Spannuth; Rosemarie Schmandt; Diana Urbauer; Len A Pennacchio; Jan-Fang Cheng; Alpa M Nick; Michael T Deavers; Alexandra Mourad-Zeidan; Hua Wang; Peter Mueller; Marc E Lenburg; Joe W Gray; Samuel Mok; Michael J Birrer; Gabriel Lopez-Berestein; Robert L Coleman; Menashe Bar-Eli; Anil K Sood
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

9.  Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis.

Authors:  Satoshi Asada; Tomosaburo Takahashi; Koji Isodono; Atsuo Adachi; Hiroko Imoto; Takehiro Ogata; Tomomi Ueyama; Hiroaki Matsubara; Hidemasa Oh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-31       Impact factor: 4.733

10.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

View more
  4 in total

Review 1.  MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.

Authors:  Adriana Fodor; Andrada Luciana Lazar; Cristina Buchman; Brandusa Tiperciuc; Olga Hilda Orasan; Angela Cozma
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

2.  MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.

Authors:  Tommaso Mazza; Massimiliano Copetti; Daniele Capocefalo; Caterina Fusilli; Tommaso Biagini; Massimo Carella; Antonio De Bonis; Nicola Mastrodonato; Ada Piepoli; Valerio Pazienza; Evaristo Maiello; Fabio Francesco di Mola; Pierluigi di Sebastiano; Angelo Andriulli; Francesca Tavano
Journal:  Oncotarget       Date:  2017-10-31

Review 3.  Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis.

Authors:  Wanying Shan; Chaoyang Sun; Bo Zhou; Ensong Guo; Hao Lu; Meng Xia; Kezhen Li; Danhui Weng; Xingguang Lin; Li Meng; Ding Ma; Gang Chen
Journal:  Oncotarget       Date:  2016-11-08

4.  Dicer protein levels elevated by mild hyperthermia promote a pro-survival phenotype.

Authors:  Anand S Devasthanam; Thomas B Tomasi
Journal:  Oncotarget       Date:  2017-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.